title: Interleukin 1 regulation of interleukin 2 and interferon-gamma gene activation in a human leukemic HSB.2 subclone.
abstract: The role of interleukin 1 (IL1) in causing IL2 and interferon-gamma (IFN-gamma) production and their associated gene activation has been studied in a human leukemic HSB.2 subclone. One of the subclones, HSB.2-C5B2 clone #28, which produced only low levels of IL2 and IFN-gamma when stimulated with phytohemagglutinin (PHA) or with a combination of phorbol-myristate-acetate (PMA) and Ca2+ ionophore, ionomycin, showed marked IL2 and IFN-gamma production in the presence of IL1. The augmentation by IL1 was observed in both dot and Northern blot analysis, indicating that IL1 regulates lymphokine genes at the pretranslational level. The kinetics of IL2 and IFN-gamma production were essentially similar for both lymphokines except that there was a faster accumulation of IFN-gamma mRNA than IL2 mRNA. In contrast to the IL2 and IFN-gamma gene activation, IL2 receptor (Tac/p55 antigen) expression was induced directly by IL1 itself as with PMA in this subclone. In these studies, IL1 action was not replaced by the drugs raising intracellular cyclic AMP (cAMP). Taken collectively, these experiments support the notion that IL1 does not trigger IL2 gene activation per se, but amplifies the preactivated lymphokine genes initiated by PMA and ionomycin, whereas IL1 can activate the IL2 receptor gene without any other known signal requirements.
authors.affiliation: Department of Medical Biology and Parasitoloy, Jichi Medical School, Tochigi.
authors.forename: T
authors.initials: T
authors.lastname: Kasahara
authors.forename: H
authors.initials: H
authors.lastname: Yagisawa
authors.forename: N
authors.initials: N
authors.lastname: Mukaida
authors.forename: H
authors.initials: H
authors.lastname: Matsumura
authors.forename: M
authors.initials: M
authors.lastname: Imai
authors.forename: K
authors.initials: K
authors.lastname: Shioiri-Nakano
mesh_terms: D015152:Blotting, Northern; D002999:Clone Cells / Q000187:drug effects / Q000276:immunology; D000242:Cyclic AMP / Q000096:biosynthesis; D015342:DNA Probes; D005434:Flow Cytometry; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D007371:Interferon-gamma / Q000096:biosynthesis / Q000235:genetics*; D007375:Interleukin-1 / Q000502:physiology*; D007376:Interleukin-2 / Q000096:biosynthesis / Q000235:genetics*; D007700:Kinetics; D012333:RNA, Messenger / Q000096:biosynthesis / Q000187:drug effects; D015375:Receptors, Interleukin-2 / Q000235:genetics; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D015533:Transcriptional Activation; D014407:Tumor Cells, Cultured
chemical_list: D015342:DNA Probes; D007375:Interleukin-1; D007376:Interleukin-2; D012333:RNA, Messenger; D015375:Receptors, Interleukin-2; D007371:Interferon-gamma; D000242:Cyclic AMP; D013755:Tetradecanoylphorbol Acetate